Hot Investor Mandate: VC With USA and Canada Offices Seeks Therapeutics, Medtech, and Consumer Health Technologies, Investing $10M+ Over Company Lifecycle

6 Jul

A life sciences venture capital firm with offices in USA and Canada has invested in over 100 companies across multiple funds. The firm typically makes initial investments ranging from $2-$6 million of equity and looks to invest $8-$12 million over the lifetime of the investment. The firm expects to make 4-6 investments over the next 12 months, and prioritizes investment opportunities that are based in USA or Canada, though they will consider opportunities beyond.  
 
The firm invests primarily in therapeutics and medical devices, and consumer health technologies. The firm generally looks for companies phase I and later that have at least some human proof-of-concept with either early human efficacy signs or very strong animal data coupled with human safety data. That said, the firm is open to earlier stage, pre-clinical companies with strong validation. The firm is agnostic in terms of modalities. 
 
The firm invests in companies throughout the United States and Canada. The firm does not look to take an active role on the management team but does look to take a board seat. 
 
If you are interested in more information about this investor and other investors tracked by LSN, please email mandates@lifesciencenation.com.

Leave a comment